Unglycosylated Mtaa expresses an Mtab-like determinant |
| |
Authors: | Aaron C Han John R Rodgers Robert R Rich |
| |
Institution: | (1) Howard Hughes Medical Institute Laboratory and the Departments of Microbiology and Immunology, and Medicine, Baylor College of Medicine, 77030 Houston, TX, USA |
| |
Abstract: | Antigenic polymorphism of the class I-like maternally transmitted antigen (Mta) is controlled by a maternally transmitted factor (Mtf) thought to reside in mitochondria. However, the mechanisms by which Mtf generates antigenic polymorphism are not known. To address this issue, we investigated a possible role of post-translational oligosaccharide addition in the formation of Mta determinants. We examined the expression of Mta on cytotoxic T lymphocyte (CTL) target cells cultured in tunicamycin (TM), a known inhibitor of asparagine(N)-linked glycosylation. Of 18 Mtab-specific CTL lines, 8 lysed TM-treated Mtaa targets. Furthermore, a subclone of one of these eight lines, 17D5.G2, lysed TM-treated targets from all Mtaa strains tested, regardless of H-2K/D haplotype. On the other hand, this CTL clone did not lyse TM-treated target cells from the Mta null, but H-2 expressing strain B10. CAS2. Therefore expression of this Mtab-like determinant is concordant with the expression of Mtaa and seems unlikely to represent a cross-reactive H-2K/D epitope. Our data suggest that an Mtab-like determinant is expressed on unglycosylated Mtaa molecules. Thus, N-linked oligosaccharides probably prevent the expression of an Mtab-like determinant on the Mtaa molecule. We discuss how Mtf may contribute to Mta polymorphism through glycosylation.Abbreviations used in this paper CAB
Con A blast
- CML
cell-mediated lympholysis
- Con A
concanavalin A
- CTL
cytotoxic T lymphocyte
- DMEM
Dulbecco's modified minimum essential medium
- FCS
fetal calf serum
- IL-2
interleukin-2
- LPS
lipopolysaccharide
- mAb
monoclonal antibody
- MLC
mixed leukocyte culture
- mMDM
modified Mishell-Dutton medium
- Mta
maternally transmitted antigen
- NK
natural killer
- sMDM
supplemented Mishell-Dutton medium
- TM
tunicamycin
-
2m
beta-2 microglobulin |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|